DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
van Ryn J, Stangier J, Haertter S. , et al.
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
Thromb Haemost 2010;
103 (06) 1116-1127
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.